InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on “Global Allogeneic Cell Therapies Market Assessment – Revenue (US$ Mn) Forecast Till 2030”
The Global Allogeneic Cell Therapy Manufacturing Market is valued at US$ 869.6 Mn in 2021, and it is expected to reach US$ 3424.1 Mn by 2030, with a CAGR of 17 % during a forecast period of 2022-2030.
The COVID-19 outbreak is now spreading rapidly around the world, leaving a path of devastation in its wake. This market research report offers the analysis for the impact of COVID 19 on leading companies in the Allogeneic Cell Therapies sector. It identifies those Allogeneic Cell Therapies market segments and companies that may benefit from COVID-19 pandemic over upcoming 5 years, as well as those market segments and companies that will lose out. The Allogeneic Cell Therapies market research report discusses in detail the impact of COVID-19 on Allogeneic Cell Therapies market for the year 2020 and beyond.
According to the latest research by InsightAce Analytic, the global allogeneic cell therapies market is expected record a promising CAGR during the period of 2022-2030. Allogeneic cell therapy uses the transfer of cells from a donor to patient. Stem cells collected from the donor whose tissue type closely matches that of the patient are predominantly used in allogenic cell therapies.
Raising prevalence of chronic diseases and increasing funding for stem cell research start-ups are driving the growth of allogeneic stem cell therapy market. Currently number of companies are developing a wide range of tissue engineered products and allogeneic cell therapies aiming to bring about an era of regenerative medicine to treat people with unmet medical needs. Additionally, rise in prevalence of cancer and cardiovascular diseases is expected to boost the global allogeneic stem cell therapy market. For instance, JKastrup has ongoing Phase II clinical trial for allogeneic adipose tissue-derived stromal/stem cell therapy in patients with ischemic heart disease and heart failure.
The Global Allogeneic cell therapy market is fragmented with presence of many players that operates in Global Allogeneic stem cell therapy uses in local as well as international market. The global Allogeneic stem cell therapy uses market reports cover clinical trial/pipeline prominent players like Atara Biotherapeutics, Artiva Biotherapeutic, Adaptimmune Therapeutics plc, Adicet Bio, Inc., Allogene Therapeutics, Athersys, Inc., BioCardia Inc., Bluebird Bio, BlueRock Therapeutics LP, Bone Therapeutics, Celyad, Capricor Therapeutics, Cellectis, Cyto Therapeutics Pty Limited, Cynata Therapeutics, Century Therapeutics, GammaDelta Therapeutics Limited, Fate Therapeutics, Osiris Therapeutics, Inc., Organogenesis Inc., Mesoblast Ltd, MEDIPOST, Nkarta, Inc., NantKwest, Pluristem Therapeutics Inc, Regeneus, Lineage Cell Therapeutics, Inc., Stempeutics, Stemedica Cell Technologies, Inc., TiGenix (Takeda) and TCR² Therapeutics among others.
Curious about this latest version of report? Obtain Report Details @ https://www.insightaceanalytic.com/report-details/global-allogeneic-cell-therapies-market/#request-for-tocproposal
- Global Allogeneic Cell Therapy Market by Cell Type Revenue (US$ Mn) Forecast 2021-2030
- Cardiosphere-Derived Cells (CDCs)
- Mesenchymal Stem Cells (MSCs)
- Hematopoietic Stem Cells (HSCs)
- Global Allogeneic Cell Therapy Market by Tissue Source Revenue (US$ Mn) Forecast 2020-2030
- Global Allogeneic Cell Therapy Market Based on Indication Revenue (US$ Mn) Forecast 2020-2030
- Acute graft-versus-host disease (GVHD)
- Chronic Ulcers and Diabetic Foot Ulcers
- Crohn’s Disease
- Cardiovascular Disease
- Solid Tumors/Cancers
- Others (Alzheimer’s Disease, etc.)
- Global Allogeneic Cell Therapy Market Based on Region Revenue (US$ Mn) Forecast 2020-2030
- Europe Allogeneic Cell Therapy Market Revenue (US$ Mn) Forecast 2020-2030
- Rest of Europe
- North America Allogeneic Cell Therapy Market Revenue (US$ Mn) Forecast 2020-2030
- Asia Pacific Allogeneic Cell Therapy Market Revenue (US$ Mn) Forecast 2020-2030
- Latin America Allogeneic Cell Therapy Market Revenue (US$ Mn) Forecast 2020-2030
- Middle East & Africa Allogeneic Cell Therapy Market Revenue (US$ Mn) Forecast 2020-2030
Why should buy this report:
- To receive a comprehensive analysis of the prospects for global allogeneic cell therapy market
- To receive industry overview and future trends global allogeneic stem cell therapy uses market
- To analyze the global allogeneic stem cell therapy uses market drivers and challenges
- To get information on global allogeneic stem cell therapy uses size value/revenue (US$ Mn) forecast till 2030
- Major Investments, Mergers & Acquisition in global allogeneic cell therapy uses industry
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ